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Objective: To determine if increasing cartilage cross-links through in vitro glycation of cartilage explants
can alter the biomechanical response of chondrocytes to compressive deformation.
Method: Bovine osteochondral explants were either incubated with cell culture solution supplemented
with (n ¼ 7) or without (n ¼ 7) ribose for 42 h in order to induce glycation. Deformation-induced changes
in cell volume, dimensions and local tissue strains were determined through confocal laser scanning
microscopy (CLSM) and the use of a custom built micro-compression device. Osteochondral explants
were also utilized to demonstrate changes in depth-wise tissue properties, biomechanical tissue prop-
erties and cross-links such as pentosidine (Pent), hydroxylysyl pyridinoline (HP) and lysyl pyridinoline
(LP).
Results: The ribose treated osteochondral samples experienced reduced cell volume deformation in the
upper tissue zone by ~8% (P ¼ 0.005), as compared the control samples, through restricting cell
expansion. In the deeper tissue zone, cell volume deformation was increased by ~12% (P < 0.001) via the
transmission of mechanical signals further into the tissue depth. Biomechanical testing of the ribose
treated osteochondral samples demonstrated an increase in the equilibrium and dynamic strain
dependent moduli (P < 0.001 and P ¼ 0.008, respectively). The biochemical analysis revealed an increase
in Pent cross-links (P < 0.001). Depth-wise tissue property analyses revealed increased levels of car-
bohydrate content, greater levels of ﬁxed charge density and an increased carbohydrate to protein ratio
from 6 to 16%, 55e100% and 72e79% of the normalized tissue thickness (from the surface), respectively,
in the ribose-treated group (P < 0.05).
Conclusion: In vitro glycation alters the biomechanical response of chondrocytes in cartilage differently
in upper and deeper zones, offering possible insights into how aging could alter cell deformation
behavior in cartilage.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Like other connective tissues within the body, articular cartilage
(AC) is susceptible to age-related changes. Nearly half of all persons
over 65 years suffer from osteoarthritis (OA) in the USA1. Hence, it is
not surprising that aging is a major risk factor in the development
of OA2. The traditional explanation offered is that mechanical
loading of AC over its life cumulatively affects it, resulting in “wear
and tear” and eventual breakdown3 of this joint tissue. However,
recent research is suggesting that this is not the case3e7.to: J.M. Fick, Department
, Kuopio FI-70211, Finland.
. Fick).
ternational. Published by Elsevier LResearchers are now focusing on understanding how cells
respond to and convert mechanical signals into biomolecules
aimed at tissue maintenance/remodelling6e8. Because the biolog-
ical responses (i.e., cell metabolism) of chondrocytes (cells) in AC
are related to the mechanical signals that they experience6e9 un-
derstanding how mechanical signals can drive cell responses is
important in understanding the aging process and how it can
trigger the development of OA. Cartilage research has so far
demonstrated that aging increases the stiffness of both the ECM
(the extracellular matrix of AC)10e15 and chondrocytes16,17, de-
creases the viscoelastic properties of the local cellular matrix
(termed the pericellular matrix or PCM)17, modiﬁes cellular meta-
bolism and metabolic pathways3e7,11,18e20 and ultimately increases
the tissue's susceptibility to fracture13e15. Age-related deterioration
of AC appears to be a problem that involves both tissue and cellular-
scale changes. Thus, understanding how cells respond totd. All rights reserved.
Fig. 1. Schematic diagram illustrating the sample preparation steps used for the
cartilage samples.
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biological differences due to tissue aging.
It is well documented that advanced glycation end products
(AGEs) accumulate within the ECM12e15,17e20 during aging, result-
ing in increased levels of cross-linking, particularly in long-lived
proteins, such as collagens. Treatment of AC with sugars, such as
ribose11,14,15,19,20 and threose13,19e21, have been used to mimic the
aging process to demonstrate that cross-linking can alter the me-
chanical properties of AC and possibly cause tissue dysfunction,
degeneration and/or OA3e9,13e15. Although these treatments pro-
vide a faster means of inducing in vitro glycation, they may not
completely mimic the age-related non-enzymatic products that
form in vivo22e25.
Other studies have investigated the biomechanical response of
chondrocytes and/or their PCM in AC by utilizing unconﬁned
compression26,27 and indentation techniques28e30combined with
confocal microscopy or by modeling the stress/strain ﬁelds within
AC31e33. These studies have provided a better understanding of
how the ECM/PCM can contribute towards modifying the response
of chondrocytes to compression. However, it is not known how or if
inducing cross-links within AC can alter the response of chon-
drocytes to deformation in cartilage.
This study's aim is to investigate how chondrocytes in normal
and artiﬁcially cross-linked osteochondral explants mechanically
respond to deformation. In order to achieve this, ribose was used to
induce cross-linking within AC. Chondrocyte deformation was
investigated through the use of a custom built micro-compression
device and confocal laser scanning microscopy (CLSM). Osteo-
chondral explants were also utilized to demonstrate changes in
biomechanical tissue properties. Biochemical analysis for cross-
links such as pentosidine (Pent), hydroxylysyl pyridinoline (HP)
and lysyl pyridinoline (LP) were performed through high-
performance liquid chromatography (HPLC)21. This enabled us to
chemically conﬁrm changes in the levels of cross-links between
untreated (control) and ribose-treated (treated) groups. Digital
densitometry (DD), Fourier Transform infrared spectroscopic im-
aging (FTIRI) and polarized light microscopy (PLM) were also per-
formed to investigate depth-wise structure and composition of the
tissues.
Methods
A brief description of the materials and methods is given here.
More details are listed in the Supplemental Material.
Sample preparation
Surface intact osteochondral plugs (ø ¼ 31 mm) were harvested
from the lateral aspect of the distal pole of patellae obtained from
seven separate bovine animals. The patellae were obtained from a
local abattoir (Atria Oyj, Kuopio, Finland) and the age of the animals
at the time of slaughter was 18 ± 1 months. The total number of
animals utilized in this study was based on previous glycation
research that demonstrated statistical differences from utilizing
patellar cartilage from a total of seven bovine animals21. Each plug
had two osteochondral samples removed (ø ¼ 8 mm; Fig. 1) and
these were randomly placed into a control or treated group (n ¼ 7/
group). Samples were then incubated (for 42 h) in cell culture
medium with 30 mM of ribose supplemented in the medium
(treated group) or without (control group) ribose supplementation.
The remnant tissue portions (Fig. 1) were carried through the
identical incubation process described for the osteochondral sam-
ples. After incubation, each osteochondral sample had a smaller
osteochondral plug (ø ¼ 2.9 mm) removed for biomechanical
testing (Fig. 1). The remaining osteochondral samples were cut intohemi-cylindrical samples and were used for cell deformation ex-
periments (Fig. 1) and then subsequent analysis for depth-wise
tissue structure and composition. The cartilage from the remnant
tissue portions was removed from underlying bone; had their wet
weights determined and analyzed biochemically for cross-links.Cell deformation experiments
The hemi-cylindrical samples were stained for 30minwith both
calcein-AM (5 mM, Invitrogen, Eugene, OR, USA) and propidium
iodide (60 mM, Sigma, Ronkonkoma, NY, USA) for live and dead
cells, respectively. Following staining, samples were positioned cut
tissue side down (with the exposed bone surface against the
loading bar) into a sample bath of a custom built stainless steel
micro-compression device [Fig. 2(a)-i]. The samples were kept
hydrated by ﬁlling the chamber with Dulbecco’s Modiﬁed Eagle
Medium (DMEM) (1 g/l low glucose, Gibco, Eugene, OR, USA)
throughout testing.
An inverted CLSM Zeiss LSM 700 (Zeiss Axio Observer .Z1, Carl
Zeiss, Oberkochen, Germany) was used for microscopic imaging
[Fig. 2(a)-ii]. To perform cell deformation experiments, the micro-
compression device was ﬁtted into the microscope stage
[Fig. 2(a)-ii]. Initial contact between the articular surface and the
side of the sample bath was visually conﬁrmed through the use of a
10 magniﬁcation objective. Tissue thickness was then estimated
by measuring the distance between the surface to cartilageebone
interface through the confocal microscope computer software (Zen
2009, Carl Zeiss, Germany). An undeformed image stack of the
entire sample (from the tissue surface to cartilageebone interface)
and higher magniﬁcation image stacks of chondrocytes within the
“upper”, “middle” and “deep” tissue zones were taken prior to
deformation (using a 10 magniﬁcation objective and an 40
magniﬁcation oil immersion objective, respectively; Fig. 2(b), (c)).
Each sample was then deformed by 15% and the tissue was allowed
to relax for 45 min21. After tissue deformation, image stacks of
chondrocytes within the “upper”, “middle” and “deep” tissue zones
and fully deformed tissue thickness image stacks were obtained
[see Fig. 2(b), (c)]. For the purposes of this study, the upper zone
was deﬁned to be from the cartilage surface up to 15% depth from
the surface, the middle zone from 15% to 41% depth from the tissue
Fig. 2. A schematic illustrating the steps utilized for CLSM and subsequent analysis. a) cross-section schematic illustrating the micro-compression device (i) used for the chon-
drocyte deformation measurements and the orientation of it positioned into the confocal laser scanning microscope (ii). The micro-compression device is positioned into the
confocal microscope device as outlined by the dashed-line box; b) CLSM images (10 low magniﬁcation and 40 higher magniﬁcation images) and adjacent idealized 3D re-
constructions obtained from cells from each inspected zone within the control tissue before (i) and after compression (ii). An idealized 3D cell reconstruction was selected to
demonstrate shape changes across each of the tissue zones before and after loading; c) CLSM images (10 low magniﬁcation and 40 higher magniﬁcation images) and 3D-cell
reconstructions obtained from each inspected zone within the treated tissue before (i) and after compression (ii). Live cells are stained green (red stained cells are dead cells). Cell
height, width and depth axis indicates cell dimensions. The superimposed yellow-dashed lines depict regions 1 through 6 which were used for determining local strains in each
tissue.
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surface34. Cell volume, height, width and depth as well as local
tissue strains were then analyzed.
The 40 magniﬁcation image stacks were imported into ImageJ
(National Institute of Health, USA). For the cell volume re-
constructions, only viable (bright green labeled cells) cells were
selected and individual cell image stacks that fully encapsulated
each selected cell were cropped from the original image stack. Eight
to ten viable cells from each of the upper, middle and deep zones
within each sample were individually selected and saved to
determine cell volume and dimensions across each group cohort
[Fig. 2(b), (c)]. Please refer to Supplemental Table 1 for cell numbers
determined across each tissue group. 3-D images of these cells
were generated by the Visualization Toolkit 5.2.0 (Kitware Inc.; see
the cell reconstructions in Fig. 2(b), (c)) and cell volumes were
calculated by an analysis script programmed with Python. A
threshold of 40% of the maximum cell ﬂuorescence intensity35 wasused in the volume calculation. Using Matlab R2007b (Mathworks
Inc., USA)29, height and width measurements of cells were deﬁned
along the major and minor cells axis. These major and minor di-
rections were opposite in the upper and deep zones [see Fig. 2(b),
(c)]. Cell depth directions (z-direction from the image stacks) were
also determined (Using Matlab) by measuring the perpendicular
distance between the cell surfaces at the point where themajor and
minor cell axis intersected in each cell. In order to investigate the
response of chondrocytes to deformation across each tissue group,
deformation-induced percent changes in cell volumes, heights,
widths and depths were calculated from the original cell volume
and dimensional data ([(after e before)/before] 100) for each
tissue zone.
Local axial and transverse cartilage strains were determined by
using the 10 magniﬁcation images. Both the before and after
deformation images from each tissue were divided into six equally
spaced regions, depth-wise, from the surface to the cartilageebone
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cell pairs were identiﬁed from each before and after deformation
image in each of the six regions from each sample (n¼ 21 cell pairs/
region within each group). Vertical and horizontal distances be-
tween these cell pairs were measured in the before and after
deformation images to determine local axial ([(before e after)/
before] 100) and transverse strains ([(after e before)/before]
100) in each tissue region.
Biomechanical testing and biochemical analysis
Biomechanical testing was performed to quantify changes in the
equilibrium and dynamicmoduli of the samples as a result of ribose
treatment (n ¼ 7 samples/group). Full thickness tissue samples
were analyzed for levels of HP, LP and Pent with an HPLC (n ¼ 7
samples/group).
Depth-wise analysis of tissue composition and structure
Optical density (from Safranin-O staining using DD)36, carbo-
hydrate content (from the carbohydrate region of the FTIRI
spectrum between 900 and 1200 cm1)37, protein content (from
the Amide I and II regions of the FTIRI spectrum between 1480
and 1700 cm1)37 and collagen orientation angle (using PLM38)
were measured for both groups in a depth-wise manner from a
total of 21 sections from each group for each method. Optical
density can be used as an estimate of ﬁxed charge density and the
carbohydrate content determined through the use of FTIRI can
provide an overall indication of the levels of glycation39 and the
relative abundance expressed in terms of a carbohydrate to
protein ratio has been indicated to reﬂect the region in the
spectrum over which glycated proteins and/or AGE-like moieties
exist37.
Statistical methods
All data was pooled according to the experimental test, tissue
group, zone andwhether the cells came from deformed tissue (only
applicable for the cell deformation experiments). The datawas then
assessed for normality by using ShapiroeWilk statistical tests
(P < 0.05). Based on this analysis, non-parametric statistical tests
were utilized for cell volume and dimensional data. Parametric
statistical tests were used for the local strain, biomechanical,
biochemical and depth-wise tissue data. All statistical analyses
were performed using IBM SPSS Statistics 21.0 (IBM Corp, Armonk,
NY, USA). Data was expressed as median or mean (accordingly)
with 95% conﬁdence intervals (CI).
Two-tailed, independent sample median tests were used to
determine if the cell volumes and cell heights, widths and depth
dimensions were different between the undeformed control and
treated groups (P < 0.05). Two-tailed, Wilcoxon Signed Rank tests
were used to determine differences in cell volumes, heights, widths
and depths for each zone from each tissue group (i.e., before vs after
deformation; P < 0.05). Two-tailed, ManneWhitney tests to
compare independent groups (i.e., control vs treated cell groups
from the same zones; P < 0.05) were used to determine differences
between the deformation-induced percent changes in cell volumes,
heights, widths and depths.
For local axial and transverse strain data, biomechanical data
(Eeq, E0, Eε), biochemical data (% water, collagen content, Pent, HP,
LP) and data on depth-wise tissue properties (DD, FTIRI and PLM),
two-tailed, Student's t-tests (due to the aforementioned
normality of the data) were utilized to determine differences
between these parameters in the control and treated groups
(P < 0.05).Results
Deformation-induced cell measurements and local strain analyses
As a result of tissue compression, cell volume increased less in
the upper zone of the treated group, as compared to the control
group. In the middle zone, cell volume changes were not different
between the groups, while a larger cell volume increase in the deep
zone of the treated group was observed, as compared to the control
group [Fig. 3(a)]. As for the deformation-induced changes in cell
dimensions in the treated group relative to the control group, the
upper zone of the treated group experienced smaller changes in cell
height, width and depth, the middle zone only experienced smaller
changes in cell height and depth, and the deep zone experienced
larger changes in cell height, width and depth [Fig. 3(b)e(d)].
Local axial and transverse strains gradually decreased from the
upper tissue layer down to the cartilageebone interface in both
groups [Fig. 4(a), (b)]. Local axial strain was observed to be smaller
in the uppermost tissue layer of the treated group relative to the
control group (region 1), while it was found to be greater in the
upper-middle region (region 3). No other differences in either local
axial strains or in the transverse strains were found between the
groups.
See Supplemental Tables 1 and 2 more details of cell volumetric
and dimensional data as well as statistical information on the
changes in cell parameters due to tissue compression in each tissue
zone from each group.
Biomechanical, biochemical, microscopic and spectroscopic analyses
Both the equilibrium and the dynamic strain dependent moduli
were greater for the treated group and no differences in the initial
dynamic moduli were observed between the groups (Table I).
Levels of Pent were greater in the treated group and levels of water,
collagen, HP and LP were similar for both groups. In the treated
group, increased levels of carbohydrate content, greater levels of
ﬁxed charge density (optical density) and an increase in the car-
bohydrate to protein ratio were found from 6 to 16%, 55e100% and
72e79% of the normalized tissue thickness (from the surface),
respectively [Fig. 5(a)e(c)]. The ﬁxed charge density, carbohydrate
content and carbohydrate to protein ratio due to ribose treatment
were also averaged across the upper, middle and deep tissue zones
[Fig. 5(d)e(f)]. Differences in ﬁxed charge density and carbohydrate
content were different in all tissue zones [Fig. 5(d), (e)], however
the carbohydrate to protein ratio was only different between the
control and treated tissue in the deep zone. Depth-wise protein
content and collagen orientation angle values were similar be-
tween the groups (data not shown).
Discussion
General characteristics of chondrocyte deformation in ribose treated
tissues
These results demonstrated that ribose treatment of osteo-
chondral explants decreased the deformation response of chon-
drocytes to tissue compression in the upper zone while increased
the deformation response of chondrocytes in the deep zone. The
smaller increase in cell volume changewithin the upper zone of the
treated tissue (relative to the control tissue) was due to a ~9% and
~7% reduction in cell width and depth (respectively). This change
was not compensated through a reduction in cell height deforma-
tion. Although no differences in cell volume changes were observed
in the middle tissue zone between the groups, smaller cell shape
changes (height, depth) were observed in the treated group. The
Fig. 3. Median values (±95% CI) of the percent change in cell volume (a), height (b), width (c) and depth (d) due to deformation from the upper, middle and deep tissue zones of the
control and treated tissue groups. Statistical differences between the control and treated groups for each tissue zone are denoted by the P-values.
Fig. 4. Mean values (±95% CI) of local axial (a) and transverse strains (b) as determined from six evenly distributed tissue depths from the surface region (1) to the deep tissue region
(6) adjacent to the osteochondral junction. Data was obtained across all regions in each sample from each group (see Fig. 2). Statistical differences between groups from each zone
are denoted by the P-values.
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Table I
Equilibrium (Eeq), initial dynamic (Eo) and strain dependent dynamic (Eε) moduli values obtained from the biomechanical testing and the biochemical parameters measured
from the control and treated tissue groups (n ¼ 7 per tissue group). Moduli values reported in MPa, water content reported as a percent (%), collagen reported in mg/mg dry
weight, Pent, HP and LP reported in mmol/mol collagen. Mean values (±95% CI) are presented and statistical differences between the groups are denoted by the superscript
letters. The P-values are generated from comparing each listed parameter between the two groups (P < 0.05 for signiﬁcant differences)
Group Biomechanical parameters (mean ± CI) Biochemical parameters (mean ± CI)
Eeq E0 Eε Water Collagen Pent HP LP
Control 0.2 ± 0.0 1.6 ± 0.4 35.2 ± 6.3 80.2 ± 3.0 0.5 ± 0.2 0.4 ± 0.6 2649 ± 438 34.2 ± 7.8
Treated 0.4 ± 0.1 1.1 ± 0.7 48.4 ± 7.9 81.9 ± 4.2 0.6 ± 0.6 3.2 ± 1.3 2423 ± 385 36.8 ± 9.7
P-value <0.001 0.189 0.008 0.452 0.860 <0.001 0.364 0.620
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group (relative to the control group) was due to a ~5% and ~6%
increase in cell expansion in both the width and depth directions
(respectively).
Potential mechanisms involved in altering biomechanical cell
responses due to ribose treatment
Several mechanisms may explain the altered biomechanical cell
responses due to in vitro glycation. The smaller change in cell vol-
umes and dimensions observed in the upper tissue zone of the
treated group (relative to the control group) may be explained by
the increase in Pent (Table I), carbohydrate content [Fig. 5(b), (e)]
and/or elevated levels of ﬁxed charge density [Fig. 5(d)]. These
observed differences may indicate an increase in tissue cross-linksFig. 5. Mean values (±95% CI) of the tissue properties plotted as a function of normalized tis
carbohydrate content determined by FTIRI37; c) carbohydrate to protein ratio determined by
deformation experiments. d) optical density; e) carbohydrate content; f) carbohydrate to pro
deep tissue zones, respectively. All data was obtained from three tissue sections per sample
differences between groups (P < 0.05) in Fig. 5(a)e(c).and/or glycation37 which may have led to increased tissue stiffness.
Because local axial strains generate tensile forces in the tangentially
oriented collagen ﬁbrils in this zone31,32, the generation of less local
axial tissue strains in the treated tissues (region 1 in Fig. 4) may
suggest that the collagen ﬁbrils are ‘pulling’ the cells (possibly
through integrin cell surface receptors anchored to the collagen
network providing a pathway for force transmission to occur from
the surrounding matrix to the cell6,8) less in the lateral direction.
The reduced volume and lateral expansion of the upper zone cells
simultaneously with the reduced local tissue strain from the
treated group may also suggest that ribose treatment of AC me-
chanically stiffens the matrix surrounding the chondrocytes
(through an increase in glycation), partially shielding them from
deformation-induced cell volume and dimensional changes. These
support the idea that the PCM, local collagen network and cross-sue depth for the control and treated groups. a) optical density determined by DD36; b)
FTIRI37. Mean values (±95% CI) determined for the zonal boundaries utilized for the cell
tein ratio. A.U. ¼ absorption unit; UZ, MZ and DZ correspond to the upper, middle and
(seven samples per group). The solid black lines (above the graphs) denote statistical
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excessive strains and stresses30e33,40. These above mentioned su-
perﬁcial zone mechanisms may also explain the smaller observed
cell shape changes (heights/depths) in the middle zone of the
treated group.
The increase in Pent (Table I), ﬁxed charge density [Fig. 5(a), (d)]
and carbohydrate to protein ratio [Fig. 5(c), (f)] may provide an
explanation for the deformation-induced increase in cell volumes
in the deep zone. These observed differences may indicate an in-
crease in tissue cross-links and/or glycated proteins, AGEs or pre-
cursors of AGEs in this zone37 which may have led to an increase in
ﬁxed charge density. The ﬁxed charge density is known to modify
swelling pressure in cartilage. Thus, the increased osmotic pressure
within the deeper zone [Fig. 5(a)] may have increased the tissue
stiffness and also caused stiffening of the local collagen network in
the ECM/PCM13,28e30. It may be that a stiffer ECM/PCM caused cells
to become more compressed in the deep tissue which, in turn,
caused elevated levels of lateral cell expansion. This is supported by
the elevated levels of local axial strain in the deeper regions of the
treated tissue suggesting that the mechanical signals were atten-
uated into greater tissue depths. Greater local strains in the deeper
tissue may have caused collapsing of the vertical collagen ﬁbrils
which could have provided the cells greater space to elongate in the
lateral direction. This is also supported by the elevated transverse
strains (although not statistically signiﬁcant) in the treated group
(region 3 in Fig. 4). However, this could also be due to the stiffer
tissue surrounding cells (due to the increased ﬁxed charge density)
‘pulling’ deeper zone cells in the lateral direction. This speculation
is anyhow consistent with earlier theoretical observations31,32.
General characteristics of biomechanical and biochemical analyses
Ribose treatment utilized in this study had a clear effect on the
elastic properties of AC, by increasing both the equilibrium
modulus and the strain dependent dynamic modulus, while not
signiﬁcantly affecting the initial dynamic modulus of the tissue.
These moduli changes due to the ribose treatment are also
consistent with a previous study that utilized threose for in vitro
glycation21. However, it should be noted that this was the ﬁrst study
where ribose was utilized to study biomechanical responses of live
cells in aging cartilage and this treatment did not appear to alter
cell viability (the green stained cells in Figs. 1(b), (c) and 3(a)). The
relatively short period of time used in this current study and lower
dosage of ribose (30 mM over 42 h of incubation) was selected in
order to minimize cell death within the osteochondral explants, as
live cells were required for imaging and the determination of
chondrocyte biomechanical responses.
Previous studies have shown that HP and LP crosslinks are not
correlated with age in human cartilage, whereas Pent cross-links
are11. In this study, only increased levels of Pent were observed,
consistent with previous studies utilizing ribose for in vitro carti-
lage glycation11,14,15. Although levels of Pent in human cartilage can
only be used as an indication of the overall amount of collagen
cross-links within the tissue, the elevated levels of Pent measured
in the current study are consistent with aging in adult
cartilage11,13,15.
Signiﬁcance of cross-linking in relation to aging and OA
In AC, AGE-induced changes in chondrocyte synthesis include
decreased collagen turnover (i.e., decreasing both collagen syn-
thesis and degradation)17 and proteoglycan synthesis (a heavily
glycosylated protein that provides compressive resistance in AC)19.
However, these changes alone do not accelerate OA20. Although
caution is warranted over the implications of our ﬁndings, AC agingmay alter the mechanical signals that cells receive in the upper and
deeper tissue zones. A change in the mechanical signals (i.e., either
elevated or reduced levels) experienced by chondrocytes in AC may
directly alter cellular biosynthesis and impair tissue health41e46.
Researchers have shown the mechanobiological importance of
abnormal mechanical conditions in AC and how they can elevate
levels of metalloproteinase MMP-13 production (a proteolytic
enzyme that is known to degrade collagen type II)9,42,43,46 and
suppress proteoglycan synthesis41,43e45. Thus, both the combined
net effect of AGE accumulation and the abnormal mechanical
loading conditions experienced by cells in AC may contribute to the
long-term tissue changes rendering it susceptible to biomechanical
dysfunction and OA. It is interesting to point out that tissue age is
positively correlated with stiffening of the collagen network11,13e15
and lower levels of tensile failure strain47, making cartilage more
brittle11,13e15. However in OA, degeneration-based changes such as
collagen network destructuring48 and proteoglycan loss49 occur,
causing tissue softening which may compensate for the effect of
tissue stiffening associated with aging. Thus, over long-term time
periods, depth-wise cell responses should also be affected by the
net contribution from aging and OA.
Limitations
Though the current study provides new insight into the defor-
mation response of chondrocytes in ribose treated tissue, there are
limitations that must be considered. In order to induce cross-
linking within the treated samples, approximately 42 h of incuba-
tion was performed on both tissue groups to allow for an appro-
priate comparison between them. However, any proteoglycan loss
from the tissues is considered negligible as previous research
demonstrated that even at 48 h of incubation there is negligible
proteoglycan loss from AC50. Additionally, incubationwith protease
inhibitors to ensure minimal proteoglycan loss from these tissues
was not possible as protease inhibitors have the potential to dam-
age subchondral bone, thus potentially altering how cells in the
osteochondral explants respond to deformation51.
In order to capture the response of chondrocytes to deformation
in the upper, middle and deep tissue zones, the cylindrical osteo-
chondral plugs were cut in half and the cells were then imaged
through the exposed cut tissue edge at a maximum focal depth of
approximately 50 mm. This sample preparation could loosen the
structure of the AC specimens which could affect the in situ
response of chondrocytes to compression26,27,30. However, this is
currently the only way to measure cells in a depth-dependent
manner, since there are no techniques at the moment which
could detect middle and deep zone cells through intact cartilage
surfaces. Furthermore, both the treated and untreated cartilage
samples underwent identical sample preparation steps so as to
allow an appropriate comparison between the tissue groups.
Cross-linking markers such as Pent, HP, and LP11 have been
shown to vary depth-wise in AC. However, not all AGEs have been
characterized in AC15,25. Thus, this makes determining zonal or
depth-wise variation in these or other speciﬁc AGE-relatedmarkers
challenging. In this current study the zonal variation of Pent, HP or
LP was not investigated. This is because an analysis of this type
would require sectioning AC into layers. This means that larger
samples, larger than thosewe used here, would have probably been
needed for a reliable HPLC analysis. Then obtaining tissue within
the distal lateral quadrant of the patellae would have been very
difﬁcult to achieve, as the cylindrical samples harvested from the
osteochondral plugs were already as large as the entire lateral
quadrant of patella (Fig. 1). Because we originally wanted to
compare the water content between tissue groups (in case ribose
treatment was altering tissue water content), we decided that
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measurement. This would have likely altered the water content
differently between the groups because stiffer ribose-treated
samples would have likely experienced less loosening of the
collagen ﬁbril tension and subsequently less tissue swelling. This
artifact of tissue swelling was also eliminated in our depth-wise
microscopic and spectroscopic analyses where fully intact tissues
attached to the subchondral bone were used. However, our FTIRI
analysis has demonstrated depth-wise differences in tissue glyca-
tion that has been suggested to be indirectly related to AGEs or
precursors of AGEs37,39.Conclusions
We investigated how in vitro glycation alters the deformation
response of chondrocytes within mechanically compressed AC.
Ribose treatment was found to decrease cell deformation responses
in the upper tissue zone, transmit mechanical forces deeper into
the tissue and increase cell deformation responses in the deeper
tissue zone. These ﬁndings highlight the importance of how gly-
cation, one of the signs of aging cartilage, can alter the biome-
chanical responses of chondrocytes in AC.Contributions
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